RxSight, Inc. (RXST) Financial Statements
Industry: Ophthalmic Goods
In fiscal 2025, RxSight reported revenue of $134.5M, down 3.9% from $139.9M the year before. Net income was -$38.9M (a -29.0% net margin), or -$0.95 per diluted share. Gross margin was 76.6% and operating margin was -35.8%. Operating activities generated -$15.5M of cash, leaving -$19.3M of free cash flow. At fiscal year end, RxSight held $311.8M in total assets against $36.1M in total liabilities, including $19.9M of cash and equivalents.
Open the full interactive RxSight financials → Quarterly statements, key ratios, valuation history and price charts.
RxSight Key Stats
| Share Price | $4.53 |
|---|---|
| Market Cap | $188.0M |
| Revenue YoY Growth | -3.9% |
| 52-Week Range | $4.53 – $13.09 |
| Shares Outstanding | 41.5 million (basic, 2026 Q2) |
RxSight Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $22.6M | $49.0M | $89.1M | $139.9M | $134.5M |
| Cost of Goods Sold | $18.1M | $27.7M | $35.3M | $41.0M | $31.5M |
| Gross Profit | $4.5M | $21.3M | $53.8M | $98.9M | $103.0M |
| Operating Income | -$52.8M | -$63.3M | -$50.1M | -$36.9M | -$48.2M |
| Pre-Tax Income | -$48.7M | -$66.7M | -$48.6M | -$27.4M | -$38.9M |
| Income Tax | $8,000 | $9,000 | $20,000 | $50,000 | $66,000 |
| Net Income | -$48.7M | -$66.8M | -$48.6M | -$27.5M | -$38.9M |
| Diluted EPS | -$3.57 | -$2.41 | -$1.41 | -$0.71 | -$0.95 |
RxSight Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $30.3M | $32.6M | $30.9M | $33.7M |
| Net Income | -$9.8M | -$9.2M | -$15.9M | -$12.1M |
| Diluted EPS | -$0.24 | -$0.22 | -$0.38 | -$0.29 |
RxSight Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $24.4M | $11.8M | $9.7M | $16.7M | $19.9M |
| Current Assets | $176.3M | $134.6M | $168.4M | $293.8M | $287.5M |
| Total Assets | $192.7M | $150.2M | $182.6M | $318.6M | $311.8M |
| Current Liabilities | $11.1M | $17.2M | $20.9M | $25.9M | $26.3M |
| Total Long-Term Debt | $39.8M | $40.2M | — | — | — |
| Total Liabilities | $54.5M | $60.3M | $22.2M | $37.3M | $36.1M |
| Shareholders' Equity | $138.2M | $89.9M | $160.4M | $281.2M | $275.7M |
RxSight Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$44.7M | -$58.9M | -$41.6M | -$16.9M | -$15.5M |
| Cash From Investing | -$81.9M | $40.0M | -$22.1M | -$99.3M | $16.9M |
| Cash From Financing | $137.3M | $6.3M | $61.5M | $123.3M | $1.9M |
| Free Cash Flow | -$46.6M | -$61.2M | -$46.4M | -$22.4M | -$19.3M |
Figures from RxSight's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full RxSight financials page for every line item.
RxSight Company Profile
| Ticker | RXST |
|---|---|
| Exchange | Nasdaq |
| Industry | Ophthalmic Goods |
| Headquarters | Aliso Viejo, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001111485 |
Frequently Asked Questions
What was RxSight's revenue in fiscal 2025?
RxSight (RXST) reported revenue of $134.5M for fiscal 2025.
What is RxSight's annual revenue history?
RxSight's annual revenue by fiscal year: 2021: $22.6M; 2022: $49.0M; 2023: $89.1M; 2024: $139.9M; 2025: $134.5M.
What was RxSight's net income in fiscal 2025?
RxSight reported net income of -$38.9M for fiscal 2025.
What was RxSight's earnings per share (EPS) in fiscal 2025?
RxSight's diluted EPS was -$0.95 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did RxSight generate in fiscal 2025?
RxSight generated -$19.3M of free cash flow in fiscal 2025.
What was RxSight's revenue last quarter?
In its most recent reported quarter (2026 Q2), RxSight reported revenue of $33.7M.
How many shares of RxSight are outstanding?
RxSight reported a weighted average of 41.5 million basic shares outstanding in 2026 Q2.
What is RxSight's market cap?
Based on its latest closing price, RxSight (RXST) has a market capitalization of about $188.0M.
When does RxSight's fiscal year end?
RxSight's fiscal year end, as registered with the SEC, is December 31.
Where is RxSight headquartered?
RxSight lists its business address in Aliso Viejo, California in its SEC filings.